Extract

Provision of optimal, safe, and effective medication use becomes more challenging as healthcare complexity increases. Pharmacists have repeatedly demonstrated the ability to improve care quality and work effectively as healthcare team extenders to improve care for patients, primarily in the outpatient setting.1-3 Leveraging pharmacist expertise by expanding practice scope is a means to ensure continued optimal pharmacotherapy plans as complexity grows.

Collaborative practice agreements (CPAs) for pharmacists are formal agreements between pharmacists and other healthcare providers, typically physicians, that allow pharmacists to perform specific patient care services at the top of their license.1 This can be transformational for teams to allow work beyond traditional dispensing duties. Typically, these agreements outline the scope of practice for the pharmacist, including, but not limited to, the service being provided, the specific patient population for the collaboration, and which established guidelines and/or evidence-based medicine will be used for decision-making where applicable. Numerous descriptions exist of successful pharmacist CPAs in the outpatient setting and disease state–specific management.4-7 In contrast, examples of inpatient pharmacist CPA use are sparse.

You do not currently have access to this article.

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.